[1]Alves R,Grimalt R. A Review of platelet-rich
plasma： history， biology， mechanism of action， and
classification [J]. Skin Appendage Disord,2018, 4（ 1） : 18-
24.
[2]Marques LF,Stessuk T,Camargo IC,et al. Plateletrich plasma（ PRP）： methodological aspects and clinical
applications[J].Platelets,2015,26（ 2） : 101-113.
[3]Etulain J. Platelets in wound healing and regenerative
medicine[J]. Platelets,2018,29（ 6） :556-568.
[4] Yuan T,Guo SC,Han P,et al.Applications of leukocyte
-and platelet-rich plasma （ L-PRP） in trauma surgery[J].
Curr Pharm Biotechnol， 2012, 13（ 7） : 1173-1184.
[5]Lynch MD， Bashtir S.Applications of plateletrich plasma in dermatology： A critical appraisal of the
literature[J]. J Dermatology Treat, 2016, 27（ 3） : 285-289.
[6]Yuan T， Zhang C Q， Tang M J. Autologous
Platelet-rich plasma enhances healing of chronic wounds[J].
wounds， 2009, 21（ 10） : 280-285.
[7] Bielecki TM.Percutaneous injection of autogenous
growth factors in patient monunion of the humerous. A case
report. J Orthopaedics， 2006， 3（ 3）： 15
[8]Yuan T， Zhang C Q， Wang J H. Augmenting tendon
and ligament repair with platelet-rich plasma （ PRP） [J].
Muscles Ligaments Tendons J, 2013,3（ 3） :139-149.
[9]Dohan E DM， Andia I， Zumstein MA， et al.Classification of platelet concentrates（ Platelet-Rich PlasmaPRP， Platelet-Rich Fibrin-PRF） for topical and infiltrative
use in orthopedic and sports medicine； current consensus，
clinical implications and perspectives Muscles[J]. Ligaments
Tendons, 2014,4（ 1） :3-9.
[10] Anitua E， Fuente MI， Muruzabal F, et al. Plasma
rich in growth factors（ PRGF） eye drops stimulates scarless
regeneration compared to autologous serum in the ocular
surface stromal fibroblasts[J]. Eye,2015, 135（ 1） : 118-126.
[11] Liu X, Ling Y, Huang J, et al. Treatment of patients
with neurotrophic keratitis stages 2 and 3 with plasma rich in
growth factors（ PRGF-Endoret） eye-drops[J]. Yan ke xue
bao,2002,18: 9-14
[12]Dell'Omo R, Cifariello F, Dell'Omo E, et al.
Influence of retinal vessel printings on metamorphopsia and
retinal architectural abnormalities in eyes with idiopathic
macular epiretinal membrane[J]. Invest Ophthalmol Vis Scien,
2013, 54: 7803-7811.
[13] Shinoda K, Kimura I, Eshita T, et al. Effects of
subtenon-injected autologous platelet-rich plasma on visual
functions in eyes with retinitis pigmentosa ： preliminary
clinical results[J]. Graefe's Arch Clin Exp Ophthalmol, 2001,
239: 941-945.
[14]Kadonosono K, Itoh N, Nomura E, et al. The effect
of immunologically safe plasma rich in growth factor eye
drops in patients with sjogern syndrome[J]. Retina ,1999,19:
536-539.
[15]Alio JL， Pastor S， Ruiz-Colecha J， et al.
Treatment of ocular SUI-face syndrome after LASIK with
autologous platelet-rich plasma[J]. Refract Surg， 2007, 23
（ 6） : 617-619.
[16]Javaloy J， Alio JL， Rodriguez AE， et al. Effert of
platelet-rich plasma in nerve regeneration after LASIK[J].J
Refract surg,2013, 29（ 3） : 213-219.